Robert Wild to Postmenopause
This is a "connection" page, showing publications Robert Wild has written about Postmenopause.
Connection Strength
3.687
-
The association between reproductive history and abdominal adipose tissue among postmenopausal women: results from the Women's Health Initiative. Hum Reprod. 2024 Aug 01; 39(8):1804-1815.
Score: 0.228
-
Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003 Mar; 88(3):1048-54.
Score: 0.207
-
Longitudinal patterns of abdominal visceral and subcutaneous adipose tissue, total body composition, and anthropometric measures in postmenopausal women: Results from the Women's Health Initiative. Int J Obes (Lond). 2023 Apr; 47(4):288-296.
Score: 0.206
-
Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women. Diabetes Care. 2022 01 01; 45(1):222-231.
Score: 0.191
-
Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):97-107.
Score: 0.188
-
Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2021 11; 30(11):2018-2029.
Score: 0.186
-
Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS). Menopause. 2021 07 26; 28(10):1108-1116.
Score: 0.185
-
Androgens and syndrome X. Menopause. 2001 Jul-Aug; 8(4):229.
Score: 0.184
-
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause. 2021 05 03; 28(6):610-618.
Score: 0.182
-
Dietary cholesterol and egg intake in relation to incident cardiovascular disease and all-cause and cause-specific mortality in postmenopausal women. Am J Clin Nutr. 2021 04 06; 113(4):948-959.
Score: 0.181
-
The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial. Menopause. 2020 11; 27(11):1265-1273.
Score: 0.176
-
The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative. Menopause. 2020 10; 27(10):1117-1125.
Score: 0.175
-
It's Absolutely Relative: The Effect of Age on the BMI-Mortality Relationship in Postmenopausal Women. Obesity (Silver Spring). 2020 01; 28(1):171-177.
Score: 0.165
-
The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
Score: 0.163
-
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study. Cancer Causes Control. 2019 Apr; 30(4):355-363.
Score: 0.157
-
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause. 2013 Mar; 20(3):254-60.
Score: 0.104
-
Intergenerational Occurrence of Premature Birth and Reproductive Health in Prematurely-Born Women in the Women's Health Initiative. Matern Child Health J. 2024 Oct; 28(10):1793-1811.
Score: 0.057
-
Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study. J Womens Health (Larchmt). 2004 Mar; 13(2):155-63.
Score: 0.055
-
Healthy Lifestyle Index and Risk of Cardiovascular Disease Among Postmenopausal Women With Normal Body Mass Index. J Am Heart Assoc. 2023 06 20; 12(12):e029111.
Score: 0.053
-
The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Menopause. 2023 01 01; 30(1):28-36.
Score: 0.050
-
The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort. Menopause. 2022 Dec 01; 29(12):1365-1374.
Score: 0.050
-
Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women's Health Initiative. Fertil Steril. 2022 05; 117(5):1038-1046.
Score: 0.048
-
The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study. Diabetes Care. 2002 Mar; 25(3):500-4.
Score: 0.048
-
Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study. Cancer Prev Res (Phila). 2022 03 01; 15(3):173-183.
Score: 0.048
-
Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Med. 2022 02; 11(4):1145-1159.
Score: 0.048
-
Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative. JAMA Netw Open. 2021 12 01; 4(12):e2138071.
Score: 0.047
-
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative. Cancer. 2021 05 15; 127(10):1658-1667.
Score: 0.045
-
Walking Volume and Speed Are Inversely Associated With Incidence of Treated Hypertension in Postmenopausal Women. Hypertension. 2020 11; 76(5):1435-1443.
Score: 0.044
-
Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative. J Vasc Surg. 2021 04; 73(4):1245-1252.e3.
Score: 0.044
-
Associations between Serum Levels of Cholesterol and Survival to Age 90 in Postmenopausal Women. J Am Geriatr Soc. 2020 02; 68(2):288-296.
Score: 0.042
-
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019 09 07; 40(34):2849-2855.
Score: 0.041
-
Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group. Climacteric. 1998 Mar; 1(1):26-32.
Score: 0.037
-
Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol. 1994 Dec; 84(6):987-95.
Score: 0.029
-
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2000 Jan; 85(1):214-8.
Score: 0.010
-
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 1998 May 13; 279(18):1445-51.
Score: 0.009